BALCX
Price
$38.33
Change
+$0.10 (+0.26%)
Updated
Sep 15 closing price
Net Assets
263.06B
JABNX
Price
$51.18
Change
+$0.24 (+0.47%)
Updated
Sep 15 closing price
Net Assets
27.56B
Interact to see
Advertisement

BALCX vs JABNX

Header iconBALCX vs JABNX Comparison
Open Charts BALCX vs JABNXBanner chart's image
American Funds American Balanced C
Price$38.33
Change+$0.10 (+0.26%)
VolumeN/A
Net Assets263.06B
Janus Henderson Balanced N
Price$51.18
Change+$0.24 (+0.47%)
VolumeN/A
Net Assets27.56B
BALCX vs JABNX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BALCX vs. JABNX commentary
Sep 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BALCX is a Buy and JABNX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BALCX has more cash in the bank: 263B vs. JABNX (27.6B). JABNX pays higher dividends than BALCX: JABNX (1.88) vs BALCX (1.16). BALCX was incepted earlier than JABNX: BALCX (25 years) vs JABNX (13 years). BALCX (1.31) is less costly to investors than JABNX (0.57). JABNX is a more actively managed with annual turnover of: 76.00 vs. BALCX (44.00). BALCX has a lower initial minimum investment than JABNX: BALCX (250) vs JABNX (1000000). BALCX (9.16) and JABNX (8.72) have marching annual gain over last year. JABNX return over 5 years is better than : 42.14 vs. BALCX (37.96).
BALCXJABNXBALCX / JABNX
Total Expense Ratio1.310.57230%
Annual Report Gross Expense Ratio1.310.57230%
Fund Existence25 years13 years-
Gain YTD12.86712.579102%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets263B27.6B953%
Annual Yield % from dividends1.161.8862%
Returns for 1 year9.168.72105%
Returns for 3 years40.6242.3696%
Returns for 5 years37.9642.1490%
Returns for 10 years71.72104.2569%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DOC18.250.17
+0.94%
Healthpeak Properties
RDHL1.50-0.01
-0.66%
Redhill Biopharma Ltd
LE15.47-0.11
-0.71%
Lands' End
OCUL12.54-0.27
-2.11%
Ocular Therapeutix
STTK1.79-0.13
-6.77%
Shattuck Labs